Emily Reeve

BPharm (Hons), PhD, Senior Research Fellow, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia; Clinical Health Sciences, University of South Australia, Adelaide, SA

Deprescribing proton pump inhibitors

Evidence supports a patient-centred approach to proton pump inhibitor deprescribing involving stepping down the dose before ceasing or switching to pro re nata use.